{
  "rss_feeds": [
    {
      "url": "https://www.fiercebiotech.com/rss/xml",
      "name": "FierceBiotech"
    },
    {
      "url": "https://www.fiercepharma.com/rss/xml", 
      "name": "FiercePharma"
    },
    {
      "url": "https://www.biopharmadive.com/feeds/news/",
      "name": "BioPharma Dive"
    },
    {
      "url": "https://www.pharmtech.com/rss",
      "name": "Pharmaceutical Technology"
    }
  ],
  "topics": [
    "Orphan Drug Designation",
    "Interim analysis were positive",
    "FDA Accelerated Approval",
    "Clinical trial results",
    "Drug approval",
    "Safety concerns",
    "Market authorization",
    "Phase 3 trial",
    "Phase 2 trial",
    "Breakthrough therapy designation",
    "EMA approval",
    "Patent expiration",
    "Biosimilar approval",
    "Merger and acquisition",
    "FDA Complete Response Letter",
    "Priority review",
    "Fast track designation",
    "New drug application",
    "Biologics license application",
    "Advisory committee meeting",
    "Label expansion",
    "Pricing and reimbursement",
    "Real-world evidence"
  ],
  "ai_settings": {
    "model": "gpt-4.1-nano",
    "classification_temperature": 0.3,
    "summary_temperature": 0.5,
    "max_summary_tokens": 700,
    "classification_threshold": 0.7
  },
  "scraping": {
    "timeout": 30,
    "max_retries": 3,
    "rate_limit_delay": 1
  },
  "processing": {
    "parallel_classification": true,
    "max_classification_workers": 5,
    "batch_classification_size": 5
  }
}